Calcium and the Pathophysiology of Neurodegenerative Disorders
Calcium and the Pathophysiology of Neurodegenerative Disorders
批准号:
10052965
负责人:
ANDREW Robert MARKS
金额:
$231.02万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-15 至 2024-07-31
关键词:
3xTg-AD mouseAPP-PS1ATP phosphohydrolaseAblationAddressAdrenergic AgentsAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease therapeuticAmyloidBehavioralBindingBiochemicalBiological AssayBiological MarkersBrainCalciumCalpainCell membraneCellsChronicClinical TrialsCognition DisordersCognitiveConsensusCyclic AMP-Dependent Protein KinasesDantroleneDataDevelopmentDissociationDrug TargetingDrug usageEndoplasmic ReticulumEnzymesEstrogen receptor positiveEtiologyFKBP1B geneFunctional disorderGeneticGlutamate ReceptorGoalsHippocampus (Brain)HistopathologyHomeostasisHumanHuman GeneticsHydroxyl RadicalITPR1 geneImpaired cognitionInositolIsoxazolesKnock-inKnock-in MouseLaboratoriesLearningLinkLong-Term DepressionLong-Term PotentiationMalignant hyperpyrexia due to anesthesiaMediatingMediator of activation proteinMemoryMemory LossMolecular ProbesMusN-MethylaspartateNeurodegenerative DisordersNeuronsOralOxidative StressOxidesParvalbuminsPathogenesisPathologicPathway interactionsPerformancePharmacologyPhosphorylationPhosphorylation SitePlayPost-Translational Protein ProcessingPost-Traumatic Stress DisordersPropionatesProtein IsoformsReportingRestRoleRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSenile PlaquesSignal TransductionSodiumSourceStressStructureSynaptic TransmissionSynaptic plasticityTestingTherapeuticTherapeutic EffectWorkabeta depositionadrenergic stressaspartate receptorcalbindincalmodulin-dependent protein kinase IIcell typecognitive functioneffective therapyfamilial Alzheimer diseasegenetic approachimprovedmouse modelneuropathologynew therapeutic targetnovelnovel drug classnovel therapeutic interventionoxidationprematurepreservationpreventreceptorrestraint stresssmall moleculesynaptic functionvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
While, the mechanism(s) underlying Alzheimer’s Disease (AD) remain obscure, hindering the development of
novel effective therapy, there is general consensus that calcium (Ca2+) plays a role. Our hypothesis is that
adrenergic and oxidative stress cause a leak in intracellular Ca2+ release channels/ryanodine receptors (RyR2)
in neurons resulting in AD neuropathology and cognitive dysfunction. In support of this hypothesis others have
shown that dantrolene, which acts on RyR channels, improves cognitive function and reduces Aβ plaques in
AD mice. However, more work is needed because the mechanisms causing RyR2 dysfunction and their
correlation with abnormal intracellular Ca2+ handling and Aβ plaques in AD remain elusive. We have
demonstrated that leaky RyR2 channels in the brain, caused by PKA hyperphosphorylation, oxidation/S-
nitrosylation, and depletion of the stabilizing subunit calstabin2 from the channel, play a key role in stress-
induced cognitive dysfunction using a chronic restraint stress murine model of PTSD with significant cognitive
dysfunction (Liu et al, Cell 2012). The stress-induced cognitive dysfunction was rescued either by
administering S107, a novel Rycal developed in the PIs laboratory that stabilizes RyR-calstabin interactions
and prevents intracellular Ca2+ leak, or by genetic ablation of the RyR2 PKA phosphorylation site at Ser2808
(S2808) in mice (RyR2-S2808A+/+ knock-in), implicating leaky RyR2 and adrenergic signaling in the etiology
of AD associated cognitive dysfunction. Our new preliminary data show that RyR2 channels in the human AD
patient brains and in three murine models of familial Alzheimer’s Disease (FAD), are PKA hyperphosphorylated,
oxidized/S-nitrosylated, and depleted of the stabilizing subunit calstabin2, a biochemical “signature” that
denotes a pathological intracellular Ca2+ leak. Preventing RyR2 leak BOTH genetically or pharmacologically
normalizes Ca2+ signaling, reduces amyloid plaque formation in APP+/-/PS1+/- and in 3XTg-AD
(APPswe/PS1Psen1/TauP301L) mice, and improves learning and memory as well as long-term potentiation (LTP)
and long-term depression (LTD). Using a genetic approach we show that knock-in mice with leaky RyR2
channels (RyR2-S2808D+/+ knock-in) have leaky hippocampal RyR2 and premature cognitive dysfunction.
The aims are: Aim 1) RyR-mediated pathological calcium dysregulation in AD: identify upstream signals. Aim 2)
RyR mediated pathological calcium dysregulation in AD: identify downstream signals. Aim 3) Determine key
calcium dependent mechanisms in AD pathogenesis.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/biom13091409
发表时间:
2023-09-19
期刊:
Biomolecules
影响因子:
5.5
作者:
[]
通讯作者:
Ryanodine receptor structure and function in heart failure
-
批准号:10628917
-
项目类别:
-
资助金额:$42.77万
-
财政年份:2023
-
负责人:ANDREW Robert MARKS
-
依托单位:
Summer Program for Under Represented Students (SPURS)
-
批准号:10583050
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2022
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Sciences for Under Represented Students
-
批准号:10669557
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2021
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Sciences for Under Represented Students
-
批准号:10115469
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2021
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Sciences for Under Represented Students
-
批准号:10397516
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2021
-
负责人:ANDREW Robert MARKS
-
依托单位:
Calcium and the physiology of diabetes
-
批准号:10357858
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants
-
批准号:10407960
-
项目类别:
-
资助金额:$76.28万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations
-
批准号:9904328
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Calcium and the physiology of diabetes
-
批准号:9923637
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations
-
批准号:10376824
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Exploring the Molecular Physiology of Atrial Fibrillation
-
批准号:10544556
-
项目类别:
-
资助金额:$77.23万
-
财政年份:2018
-
负责人:ANDREW Robert MARKS
-
依托单位:
Exploring the Molecular Physiology of Atrial Fibrillation
-
批准号:10366410
-
项目类别:
-
资助金额:$76.76万
-
财政年份:2018
-
负责人:ANDREW Robert MARKS
-
依托单位:
Exploring the Molecular Physiology of Atrial Fibrillation
-
批准号:10063900
-
项目类别:
-
资助金额:$71.81万
-
财政年份:2018
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Translational Research
-
批准号:10546477
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2014
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Translational Research
-
批准号:8608392
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2014
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Translational Research
-
批准号:10408665
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2014
-
负责人:ANDREW Robert MARKS
-
依托单位:
Administrative Core
-
批准号:8236898
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci
-
批准号:8106862
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci
-
批准号:8301586
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci
-
批准号:8656743
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
海外基金